Your browser doesn't support javascript.
loading
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data.
Hinata, Nobuyuki; Yonese, Junji; Masui, Satoru; Nakai, Yasutomo; Shirotake, Suguru; Tatsugami, Katsunori; Inamoto, Teruo; Nozawa, Masahiro; Ueda, Kosuke; Etsunaga, Toru; Osawa, Takahiro; Uemura, Motohide; Kimura, Go; Numakura, Kazuyuki; Yamana, Kazutoshi; Miyake, Hideaki; Fukasawa, Satoshi; Ochi, Kenya; Kaneko, Hirokazu; Uemura, Hirotsugu.
Afiliação
  • Hinata N; Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Yonese J; Department of Urology, Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Masui S; Division of Reparative and Regenerative Medicine, Nephro-Urologic Surgery and Andrology, Institute of Medical Life Science, Mie University Graduate School of Medicine, Mie, Japan.
  • Nakai Y; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
  • Shirotake S; Department of Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Tatsugami K; Department of Urology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Inamoto T; Department of Urology, Osaka Medical College, Osaka, Japan.
  • Nozawa M; Department of Urology, Kindai University, Faculty of Medicine, 377-2, OhnoHigashi, Osakasayama-shi, Osaka, 589-8511, Japan.
  • Ueda K; Department of Urology, Kurume University School of Medicine, Fukuoka, Japan.
  • Etsunaga T; Department of Urology, Isesaki Municipal Hospital, Gunma, Japan.
  • Osawa T; Department of Urology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.
  • Uemura M; Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kimura G; Department of Urology, Nippon Medical School Hospital, Tokyo, Japan.
  • Numakura K; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Yamana K; Department of Urology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Miyake H; Department of Urology, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Fukasawa S; Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan.
  • Ochi K; Ono Pharmaceutical Co., Ltd, Osaka, Japan.
  • Kaneko H; Bristol-Myers Squibb K.K, Tokyo, Japan.
  • Uemura H; Department of Urology, Kindai University, Faculty of Medicine, 377-2, OhnoHigashi, Osakasayama-shi, Osaka, 589-8511, Japan. huemura@med.kindai.ac.jp.
Int J Clin Oncol ; 25(8): 1533-1542, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32519026
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Nivolumabe / Neoplasias Renais Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Nivolumabe / Neoplasias Renais Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão